Evidence map›Paper›PMID 30406847›Full record

Trial reportJournal of gastroenterology2019

Diagnostic efficacy of dual-focus endoscopy with narrow-band imaging using simplified dyad criteria for superficial esophageal squamous cell carcinoma.

Akira Dobashi, Kenichi Goda, Hiroto Furuhashi, Hiroaki Matsui, Yuko Hara, Shunsuke Kamba, Masakuni Kobayashi, Kazuki Sumiyama, Shinichi Hirooka, Shigeharu Hamatani and 3 more

Abstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Electronic chromo-endoscopy: technical details and a clinical perspective.Translational gastroenterology and hepatology · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Akira DobashiDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan. akira.dobashi1980@gmail.com.ORCID http://orcid.org/0000-0002-4882-3220
Kenichi GodaDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Hiroto FuruhashiDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Hiroaki MatsuiDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Yuko HaraDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Shunsuke KambaDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Masakuni KobayashiDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Kazuki SumiyamaDepartment of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan.
Shinichi HirookaDepartment of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
Shigeharu HamataniDepartment of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
Elizabeth RajanDevelopmental Endoscopy Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Masahiro IkegamiDepartment of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
Hisao TajiriDepartment of Innovative Interventional Endoscopy Research, The Jikei University School of Medicine, Tokyo, Japan.
Jikei University School of Medicine · JPMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur previous studies have shown the diagnostic utility of a newly developed dual-focus endoscope with narrow-band imaging (DF-NBI) and simplified dyad criteria for detection of superficial esophageal squamous cell carcinoma (SESCC). This clinical trial aimed to study the diagnostic efficacy of DF-NBI with dyad criteria for detecting SESCC compared to white light imaging (WLI).

methodsThis was a single-arm prospective comparative trial. We enrolled 170 consecutive high-risk patients for esophageal squamous cell carcinoma. Patients were initially examined with WLI by one independent endoscopist and then the other performed DF-NBI blinded to the WLI diagnosis to avoid a carry-over effect. Lesions showing proliferation and/or various shapes of intrapapillary capillary loops (IPCL) under DF-NBI (i.e., dyad criteria) were endoscopically diagnosed as SESCC including high-grade intraepithelial neoplasia. The primary endpoint was sensitivity of WLI and DF-NBI for detecting SESCC. The secondary endpoints were the diagnostic performance (i.e., specificity and accuracy) and inter/intra-observer concordance of DF-NBI with dyad criteria.

resultsA total 77 SESCCs were detected. The sensitivity of DF-NBI for SESCC was significantly higher than that of WLI (91% vs. 51%, P < 0.001). The specificity and accuracy of WLI and DF-NBI using dyad criteria were 100% vs. 84%, and 86% vs. 86%, respectively. Various shapes and proliferation of IPCL showed the highest value in inter-observer and intra-observer agreements (κ = 0.77 and 0.82, respectively).

conclusionDF-NBI combined with dyad criteria may be a promising technique with a high sensitivity for diagnosis of SESCC and high inter/intra-observer agreement.

Indexed as

AgedEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagoscopyFemaleHumansMaleMiddle AgedNarrow Band ImagingProspective StudiesSensitivity and SpecificityDiagnosisDual-focusEsophageal squamous cell carcinomaIntrapapillary capillary loopNarrow-band imaging

Identifiers

PMID30406847
OpenAlexW2899877035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.